Fractional COO
Visionary and results-driven Executive with nearly two decades of experience bridging the gap between corporate strategy and technological innovation within the life sciences and healthcare sectors. Proven track record of scaling organizations, optimizing performance metrics, and leading cross-functional teams of 30 plus (PMO, QA, RA, IT, and Procurement) to deliver operational excellence and financial growth. Expert in navigating complex M&A due diligence, post-acquisition integration, and enterprise-wide Agile transformations. A continuous-learning leader committed to empowering multidisciplinary teams, securing board consensus, and turning complex product road maps into high-yield corporate assets. Successfully guided HUB Organoids B.V., acquisition by Merck KGaA, Darmstadt, Germany, Life Science Business. A leader served as Board Member.
Companies looking for this kind of leader are typically buying decision support, operating cadence, and hands-on executive judgment in one engagement.